{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:52:45Z","timestamp":1790175165259,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T00:00:00Z","timestamp":1362441600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0057672","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T22:31:24Z","timestamp":1362522684000},"page":"e57672","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":56,"title":["Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans"],"prefix":"10.1371","volume":"8","author":[{"given":"Ying-Lien","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia N.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna F.","family":"Averette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Perfect","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Heitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,5]]},"reference":[{"key":"ref1","unstructured":"Calderone RA (2002) Candida and Candidiasis (Chapter 1: Introduction and historical perspectives): p.3\u201313. American Society for Microbiology, Washington, DC."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"165rv113","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"GD Brown","year":"2012","journal-title":"Sci Transl Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1128\/AAC.49.9.3640-3645.2005","article-title":"Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality","volume":"49","author":"M Morrell","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1128\/AAC.05900-11","article-title":"Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring","volume":"56","author":"MJ Dolton","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijantimicag.2011.07.008","article-title":"Overview of safety experience with caspofungin in clinical trials conducted over the first 15 years: a brief report","volume":"38","author":"AL Ngai","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrmicro1680","article-title":"Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections","volume":"5","author":"WJ Steinbach","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12281-010-0027-5","article-title":"On the roles of calcineurin in fungal growth and pathogenesis","volume":"4","author":"YL Chen","year":"2010","journal-title":"Curr Fungal Infect Rep"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2011.11.001","article-title":"Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment","volume":"125","author":"MA Pfaller","year":"2012","journal-title":"Am J Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1111\/j.1601-0825.1997.tb00336.x","article-title":"Stable azole drug resistance associated with a substrain of <italic>Candida albicans<\/italic> from an HIV-infected patient","volume":"3","author":"TC White","year":"1997","journal-title":"Oral Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1128\/AAC.41.7.1482","article-title":"Increased mRNA levels of <italic>ERG16<\/italic>, <italic>CDR<\/italic>, and <italic>MDR1<\/italic> correlate with increases in azole resistance in <italic>Candida albicans<\/italic> isolates from a patient infected with human immunodeficiency virus","volume":"41","author":"TC White","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1128\/AAC.01162-08","article-title":"Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for <italic>Candida albicans<\/italic>: implications for interpretive breakpoints","volume":"53","author":"G Garcia-Effron","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJM199610103351501","article-title":"A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team","volume":"335","author":"SM Hammer","year":"1996","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1093\/clinids\/18.4.516","article-title":"Combination therapy for infection due to human immunodeficiency virus type 1","volume":"18","author":"AM Caliendo","year":"1994","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1056\/NEJM199512073332204","article-title":"A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection","volume":"333","author":"M Markowitz","year":"1995","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/AAC.48.1.137-142.2004","article-title":"Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis","volume":"48","author":"D Andes","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1128\/AAC.42.6.1387","article-title":"Evaluation of endpoints for antifungal susceptibility determinations with LY303366","volume":"42","author":"ME Klepser","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"FC Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1128\/AAC.01053-05","article-title":"Impact of antimicrobial dosing regimen on evolution of drug resistance in vivo: fluconazole and <italic>Candida albicans<\/italic>","volume":"50","author":"D Andes","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1128\/AAC.00999-09","article-title":"Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against <italic>Aspergillus fumigatus<\/italic>","volume":"54","author":"J Meletiadis","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1445-5994.2008.01726.x","article-title":"Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders","volume":"38","author":"LJ Worth","year":"2008","journal-title":"Intern Med J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0076-6879(91)94027-A","article-title":"Transformation of yeast directly with synthetic oligonucleotides","volume":"194","author":"RP Moerschell","year":"1991","journal-title":"Methods Enzymol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1073\/pnas.85.2.524","article-title":"Transformation of yeast with synthetic oligonucleotides","volume":"85","author":"RP Moerschell","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12281-010-0018-6","article-title":"Use of antifungal combination therapy: agents, order, and timing","volume":"4","author":"MD Johnson","year":"2010","journal-title":"Curr Fungal Infect Rep"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1128\/AAC.00393-06","article-title":"Calcineurin promotes infection of the cornea by <italic>Candida albicans<\/italic> and can be targeted to enhance fluconazole therapy","volume":"50","author":"C Onyewu","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1128\/AAC.01510-09","article-title":"Multilaboratory testing of two-drug combinations of antifungals against <italic>Candida albicans<\/italic>, <italic>Candida glabrata<\/italic>, and <italic>Candida parapsilosis<\/italic>","volume":"55","author":"V Chaturvedi","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1128\/AAC.00959-10","article-title":"Activities of triazole-echinocandin combinations against <italic>Candida<\/italic> species in biofilms and as planktonic cells","volume":"55","author":"A Chatzimoschou","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1128\/AAC.49.8.3544-3545.2005","article-title":"In vitro interaction of posaconazole and caspofungin against clinical isolates of <italic>Candida glabrata<\/italic>","volume":"49","author":"ER Oliveira","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1128\/AAC.00829-05","article-title":"Interaction between posaconazole and caspofungin in concomitant treatment of mice with systemic <italic>Aspergillus<\/italic> infection","volume":"50","author":"A Cacciapuoti","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/emboj\/21.4.546","article-title":"Calcineurin is essential for survival during membrane stress in <italic>Candida albicans<\/italic>","volume":"21","author":"MC Cruz","year":"2002","journal-title":"EMBO J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/jac\/42.6.747","article-title":"Synergic effects of tacrolimus and azole antifungal agents against azole-resistant <italic>Candida albicans<\/italic> strains","volume":"42","author":"S Maesaki","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.44.9.2373-2381.2000","article-title":"Potent synergism of the combination of fluconazole and cyclosporine in <italic>Candida albicans<\/italic>","volume":"44","author":"O Marchetti","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1128\/EC.00310-10","article-title":"Calcineurin controls drug tolerance, hyphal growth, and virulence in <italic>Candida dubliniensis<\/italic>","volume":"10","author":"YL Chen","year":"2011","journal-title":"Eukaryot Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1534\/g3.112.002279","article-title":"Convergent evolution of calcineurin pathway roles in thermotolerance and virulence in <italic>Candida glabrata<\/italic>","volume":"2","author":"YL Chen","year":"2012","journal-title":"G3 (Bethesda)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.4161\/cib.18833","article-title":"Comparative analysis of calcineurin signaling between <italic>Candida dubliniensis<\/italic> and <italic>Candida albicans<\/italic>","volume":"5","author":"J Zhang","year":"2012","journal-title":"Commun Integr Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e44192","DOI":"10.1371\/journal.pone.0044192","article-title":"Calcineurin is required for pseudohyphal growth, virulence, and drug resistance in <italic>Candida lusitaniae<\/italic>","volume":"7","author":"J Zhang","year":"2012","journal-title":"PLoS One"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.47.7.2373-2375.2003","article-title":"Addition of caspofungin to fluconazole does not improve outcome in murine candidiasis","volume":"47","author":"JR Graybill","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1086\/501457","article-title":"A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV\/AIDS","volume":"42","author":"JA Vazquez","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/283239","article-title":"Successful treatment of chronic mucocutaneous candidiasis caused by azole-resistant <italic>Candida albicans<\/italic> with posaconazole","volume":"(283239)","author":"D Firinu","year":"2011","journal-title":"Clin Dev Immunol 2011"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2958.2003.03430.x","article-title":"The <italic>Candida albicans<\/italic> Cdr2p ATP-binding cassette (ABC) transporter confers resistance to caspofungin","volume":"48","author":"M Schuetzer-Muehlbauer","year":"2003","journal-title":"Mol Microbiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/AAC.00184-09","article-title":"In vitro interactions between antifungals and immunosuppressive drugs against zygomycetes","volume":"53","author":"E Dannaoui","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jac\/dkq020","article-title":"In vitro interaction of posaconazole with calcineurin inhibitors and sirolimus against zygomycetes","volume":"65","author":"S Narreddy","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Lewis RE, Ben-Ami R, Best L, Albert N, Walsh TJ, et al.. (2013) Tacrolimus Enhances the Potency of Posaconazole Against <italic>Rhizopus oryzae<\/italic> In vitro and In an Experimental Models of Mucormycosis. J Infect Dis.","DOI":"10.1093\/infdis\/jis767"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1128\/AAC.44.11.2932-2938.2000","article-title":"Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to <italic>Candida albicans<\/italic>","volume":"44","author":"O Marchetti","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/FTD.0b013e31819de6fd","article-title":"Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis","volume":"31","author":"M Berge","year":"2009","journal-title":"Ther Drug Monit"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.3109\/13693786.2010.505203","article-title":"Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients","volume":"48","author":"EM Billaud","year":"2010","journal-title":"Med Mycol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00328721","article-title":"Isolation of the <italic>Candida albicans<\/italic> gene for orotidine-5\u2032-phosphate decarboxylase by complementation of <italic>S. cerevisiae ura3<\/italic> and <italic>E. coli pyrF<\/italic> mutations","volume":"198","author":"AM Gillum","year":"1984","journal-title":"Mol Gen Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0057672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:36:15Z","timestamp":1589034975000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0057672"}},"subtitle":[],"editor":[{"given":"Yong-Sun","family":"Bahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,5]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0057672","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,5]]}}}